Published in Adv Exp Med Biol on January 01, 2010
Exposure to tri-o-cresyl phosphate detected in jet airplane passengers. Toxicol Appl Pharmacol (2011) 1.03
Biomarkers of organophosphorus (OP) exposures in humans. Neurotoxicology (2011) 0.99
Protein adducts as biomarkers of exposure to organophosphorus compounds. Toxicology (2012) 0.83
Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures. Chem Biol Interact (2012) 0.78
Analysis of biomarker utility using a PBPK/PD model for carbaryl. Front Pharmacol (2014) 0.77
Assessing biomarkers and neuropsychological outcomes in rural populations exposed to organophosphate pesticides in Chile--study design and protocol. BMC Public Health (2015) 0.75
Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants. Chem Biol Interact (2012) 0.75
Exposure to triaryl phosphates: metabolism and biomarkers of exposure. J Biol Phys Chem (2011) 0.75
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci U S A (1977) 2.97
Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol (2004) 2.67
Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem (2006) 2.55
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol (2005) 2.05
Tricresyl phosphates and cholinesterase. Biochem J (1954) 2.00
Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem Res Toxicol (2002) 1.47
Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol Sci (2004) 1.35
The toxicity of commercial jet oils. Environ Res (2002) 1.31
Cholinesterase inhibition: complexities in interpretation. Clin Chem (1995) 1.29
Biological activity of a trio-cresyl phosphate metabolite. Nature (1961) 1.26
Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol Rev (1959) 1.25
LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY. J Med Chem Biol Radiol Def (2005) 1.24
Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol Pharmacol (2000) 1.10
Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number. J Biol Chem (1978) 1.08
Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Toxicol Sci (2005) 1.06
Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods (1997) 1.03
The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Arch Toxicol (1999) 1.02
Purification and properties of acylamino acid-releasing enzyme from rat liver. J Biochem (1975) 0.99
Coordination of oxidized protein hydrolase and the proteasome in the clearance of cytotoxic denatured proteins. Biochem Biophys Res Commun (2004) 0.96
New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol (1997) 0.95
The Public Health Service and Jamaica ginger paralysis in the 1930s. Public Health Rep (1995) 0.94
Use of procainamide gels in the purification of human and horse serum cholinesterases. Biochem J (1983) 0.92
Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide. J Neurochem (2007) 0.90
Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim Biophys Acta (2000) 0.89
Purification and partial characterization of alpha-N-acylpeptide hydrolase from bovine liver. J Biol Chem (1978) 0.89
Acetylleucine chloromethyl ketone, an inhibitor of acylpeptide hydrolase, induces apoptosis of U937 cells. Biochem Biophys Res Commun (1999) 0.85
Human monocyte carboxylesterase. Purification and kinetics. J Biol Chem (1990) 0.81
Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants. Toxicol Appl Pharmacol (2007) 0.80
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics (2010) 13.35
Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods (2007) 8.94
An expansive human regulatory lexicon encoded in transcription factor footprints. Nature (2012) 7.27
A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol (2003) 6.32
Assigning significance to peptides identified by tandem mass spectrometry using decoy databases. J Proteome Res (2007) 5.57
A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe (2010) 4.98
Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature (2006) 4.96
Coordinate regulation of energy transduction modules in Halobacterium sp. analyzed by a global systems approach. Proc Natl Acad Sci U S A (2002) 4.96
Aminoglycoside antibiotics induce bacterial biofilm formation. Nature (2005) 4.93
MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. Rapid Commun Mass Spectrom (2004) 4.76
Analysis of peptide MS/MS spectra from large-scale proteomics experiments using spectrum libraries. Anal Chem (2006) 4.16
Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect (2004) 3.66
The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat Cell Biol (2006) 3.22
Genetic basis of proteome variation in yeast. Nat Genet (2007) 3.04
Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation (2009) 2.96
A quantitative atlas of polyadenylation in five mammals. Genome Res (2012) 2.87
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol (2007) 2.87
Label-free comparative analysis of proteomics mixtures using chromatographic alignment of high-resolution muLC-MS data. Anal Chem (2008) 2.77
High-speed data reduction, feature detection, and MS/MS spectrum quality assessment of shotgun proteomics data sets using high-resolution mass spectrometry. Anal Chem (2007) 2.75
Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol (2007) 2.68
Posterior error probabilities and false discovery rates: two sides of the same coin. J Proteome Res (2007) 2.61
Experimental protein mixture for validating tandem mass spectral analysis. OMICS (2002) 2.54
Code developments to improve the efficiency of automated MS/MS spectra interpretation. J Proteome Res (2003) 2.53
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology (2005) 2.49
The study of macromolecular complexes by quantitative proteomics. Nat Genet (2003) 2.44
Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem (2004) 2.40
Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics (2012) 2.29
Gene expression analyzed by high-resolution state array analysis and quantitative proteomics: response of yeast to mating pheromone. Mol Cell Proteomics (2004) 2.22
Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology (2005) 2.21
Dual-pressure linear ion trap mass spectrometer improving the analysis of complex protein mixtures. Anal Chem (2009) 2.20
Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res (2009) 2.20
Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun (2006) 2.18
Comparison of database search strategies for high precursor mass accuracy MS/MS data. J Proteome Res (2010) 2.17
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Rapid and accurate peptide identification from tandem mass spectra. J Proteome Res (2008) 2.13
The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci U S A (2013) 2.10
Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol (2012) 2.10
Effects of modified digestion schemes on the identification of proteins from complex mixtures. J Proteome Res (2006) 2.09
A widespread bacterial type VI secretion effector superfamily identified using a heuristic approach. Cell Host Microbe (2012) 2.08
Genetic variation shapes protein networks mainly through non-transcriptional mechanisms. PLoS Biol (2011) 2.08
LPS remodeling is an evolved survival strategy for bacteria. Proc Natl Acad Sci U S A (2012) 2.05
Rapid empirical discovery of optimal peptides for targeted proteomics. Nat Methods (2011) 2.02
Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol (2003) 2.01
Peptide charge state determination for low-resolution tandem mass spectra. Proc IEEE Comput Syst Bioinform Conf (2005) 1.97
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. Anal Chem (2009) 1.96
Similarity among tandem mass spectra from proteomic experiments: detection, significance, and utility. Anal Chem (2003) 1.94
Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol (2002) 1.93
Efficient marginalization to compute protein posterior probabilities from shotgun mass spectrometry data. J Proteome Res (2010) 1.91
Use of shotgun proteomics for the identification, confirmation, and correction of C. elegans gene annotations. Genome Res (2008) 1.90
Quantitative proteomic analysis of Myc oncoprotein function. EMBO J (2002) 1.89
A microcapillary trap cartridge-microcapillary high-performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine operation. Rapid Commun Mass Spectrom (2003) 1.85
Comparative metaproteomics reveals ocean-scale shifts in microbial nutrient utilization and energy transduction. ISME J (2010) 1.80
Modulation of paraoxonase (PON1) activity. Biochem Pharmacol (2005) 1.80
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics (2011) 1.79
Approaching complete peroxisome characterization by gas-phase fractionation. Electrophoresis (2002) 1.78
An E3 ubiquitin ligase prevents ectopic localization of the centromeric histone H3 variant via the centromere targeting domain. Mol Cell (2010) 1.78
Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ Cardiovasc Genet (2008) 1.76
PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics (2006) 1.75
Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell Microbiol (2009) 1.66
Post analysis data acquisition for the iterative MS/MS sampling of proteomics mixtures. J Proteome Res (2009) 1.63
Shotgun collision-induced dissociation of peptides using a time of flight mass analyzer. Proteomics (2003) 1.62
Pro-CrossLink. Software tool for protein cross-linking and mass spectrometry. Anal Chem (2006) 1.61
Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics (2007) 1.58
Chemical cross-linking and mass spectrometry as a low-resolution protein structure determination technique. Anal Chem (2010) 1.58
A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog (2008) 1.58
Shotgun proteomics: tools for the analysis of complex biological systems. Curr Opin Mol Ther (2002) 1.57
Characterization of protein cross-links via mass spectrometry and an open-modification search strategy. Anal Chem (2008) 1.56
Quantitative profiling of ubiquitylated proteins reveals proteasome substrates and the substrate repertoire influenced by the Rpn10 receptor pathway. Mol Cell Proteomics (2007) 1.53
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain (2011) 1.53
Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med (2001) 1.51
Protein identification using top-down. Mol Cell Proteomics (2011) 1.50
Multiplexed MS/MS for improved data-independent acquisition. Nat Methods (2013) 1.48
Modeling peptide fragmentation with dynamic Bayesian networks for peptide identification. Bioinformatics (2008) 1.48
Proteomic analysis of human prostasomes. Prostate (2003) 1.45
Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides. Anal Chem (2008) 1.44
Panorama: a targeted proteomics knowledge base. J Proteome Res (2014) 1.43
Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. Anal Chem (2010) 1.43
Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin Chim Acta (2005) 1.42
Expression of human paraoxonase (PON1) during development. Pharmacogenetics (2003) 1.40
Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol Aging (2005) 1.39
Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res (2005) 1.39
Quantitative proteomic analysis indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates from cystic fibrosis airways. Proc Natl Acad Sci U S A (2003) 1.39
Quantitative mass spectrometry reveals a role for the GTPase Rho1p in actin organization on the peroxisome membrane. J Cell Biol (2004) 1.38
Structural heterogeneity and environmentally regulated remodeling of Francisella tularensis subspecies novicida lipid A characterized by tandem mass spectrometry. J Am Soc Mass Spectrom (2007) 1.37
Proteomic discovery of previously unannotated, rapidly evolving seminal fluid genes in Drosophila. Genome Res (2009) 1.37
Using BiblioSpec for creating and searching tandem MS peptide libraries. Curr Protoc Bioinformatics (2007) 1.35
Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas (2007) 1.35
Organellar proteomics reveals Golgi arginine dimethylation. Mol Biol Cell (2004) 1.35
Molecular mechanisms underlying genotype-dependent responses to dietary restriction. Aging Cell (2013) 1.31
A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics (2007) 1.31
Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell (2014) 1.30
Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genomics (2005) 1.30